# FDA 483 - Frontage Clinical Services, Inc. - May 20, 2014

Source: https://www.globalkeysolutions.net/records/483/frontage-clinical-services-inc/5f3e1f77-8b40-41a8-9ad6-4bb43bd079d9

> FDA 483 for Frontage Clinical Services, Inc. on May 20, 2014. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Frontage Clinical Services, Inc.
- Inspection Date: 2014-05-20
- Product Type: drugs
- Office Name: New Jersey District Office
- Summary: An FDA inspection of Frontage Clinical Services, Inc. in Hackensack, NJ, a bioavailability/bioequivalency clinical investigator, revealed one significant observation. The firm failed to retain reserve samples of test articles used in a bioavailability study. This indicates a lapse in proper sample retention procedures for clinical research.

## Related Officers

- [Regulatory Officer](https://www.globalkeysolutions.net/people/peter-r-lenahan/c695dac2-5447-434b-801e-f95e6acf05f1)

Company: https://www.globalkeysolutions.net/companies/frontage-clinical-services-inc/77c4cddc-2196-4091-a026-3243053cebc3

Office: https://www.globalkeysolutions.net/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248